方盛制药终止筹划定增 7月1日复牌

中国证券网讯 （记者 陈天弋）方盛制药(603998,股吧)6月30日晚间公告，根据目前进展情况，公司决定终止筹划非公开发行股份事项，公司承诺三个月内不再筹划非公开发行股份事项。公司股票7月1日复牌。

China Securities Network (reporter Chen Tianyi) Fangsheng Pharmaceutical (603998, Guba) June 30 evening announcement, according to the current situation, the company decided to terminate the planning of non-public offering of stock items, the company promised three months longer planning non-public offering of stock items. Company shares resume trading in July 1st.